Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) Invested Capital (2019 - 2026)

Sotera Health has reported Invested Capital over the past 7 years, most recently at $703.3 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 73.23% year-over-year to $703.3 million; the TTM value through Dec 2025 reached $703.3 million, down 73.23%, while the annual FY2025 figure was $703.3 million, 73.23% down from the prior year.
  • Invested Capital for Q4 2025 was $703.3 million at Sotera Health, down from $2.7 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $2.7 billion in Q2 2025 and troughed at $703.3 million in Q4 2025.
  • A 5-year average of $2.4 billion and a median of $2.6 billion in 2023 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: surged 446.22% in 2021 and later plummeted 73.23% in 2025.
  • Year by year, Invested Capital stood at $2.3 billion in 2021, then dropped by 1.51% to $2.3 billion in 2022, then increased by 16.46% to $2.7 billion in 2023, then decreased by 1.66% to $2.6 billion in 2024, then plummeted by 73.23% to $703.3 million in 2025.
  • Business Quant data shows Invested Capital for SHC at $703.3 million in Q4 2025, $2.7 billion in Q3 2025, and $2.7 billion in Q2 2025.